Form D · Biotechnology

CV Ingenuity Corp.

Fremont, CA · CIK 0001464852

Offering snapshot reported Nov 29, 2012 · SEC filing

Reported sold
$11.1M
Offering amount: $11.1M
Investors reported
25
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 19, 2012
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 29, 2012Initial$11,136,154No comparison25SEC filing
Oct 14, 2011Amendment$17,383,237$1,371,994vs Oct 5, 201123SEC filing
Oct 5, 2011Initial$16,011,243No comparison19SEC filing
Jan 24, 2011Amendment$3,790,000$540,000vs Oct 18, 201010SEC filing
Oct 18, 2010Amendment$3,250,000$250,000vs Sep 9, 201010SEC filing
Sep 9, 2010Initial$3,000,000No comparison10SEC filing
May 26, 2009Initial$1,750,000No comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-187617

Source: Form D, filed Nov 29, 2012. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Louis Cannon Director
Ryan Drant Director
Bill Facteau Director
Allan Johnston Director
Justin Klein Director
Douglas Koo Executive
Lee Meisel Director
Eugene T. Michal Executive
Matthew J. Pollman Executive
Douglas S. Rohlen Director, Executive
Duke Rohlen Director, Executive
Robert Thomas Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
6531 Dumbarton Circle
Fremont, CA, 94555